210 related articles for article (PubMed ID: 17368952)
1. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
Liu D; Bao F; Wen J; Liu J
Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
[TBL] [Abstract][Full Text] [Related]
2. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
3. Differing effects of copper,zinc superoxide dismutase overexpression on neurotoxicity elicited by nitric oxide, reactive oxygen species, and excitotoxins.
Ying W; Anderson CM; Chen Y; Stein BA; Fahlman CS; Copin JC; Chan PH; Swanson RA
J Cereb Blood Flow Metab; 2000 Feb; 20(2):359-68. PubMed ID: 10698074
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
5. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
6. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Calabrese V
Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
[TBL] [Abstract][Full Text] [Related]
7. Proteome analysis in hippocampus of mice overexpressing human Cu/Zn-superoxide dismutase 1.
Shin JH; London J; Le Pecheur M; Weitzdoerfer R; Hoeger H; Lubec G
Neurochem Int; 2005 Jun; 46(8):641-53. PubMed ID: 15863242
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression by retrograde transport of adenoviral vectors with Cre-loxP recombination system in motor neurons of mutant SOD1 transgenic mice.
Yamashita S; Mita S; Arima T; Maeda Y; Kimura E; Nishida Y; Murakami T; Okado H; Uchino M
Gene Ther; 2001 Jul; 8(13):977-86. PubMed ID: 11438832
[TBL] [Abstract][Full Text] [Related]
9. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
11. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
[TBL] [Abstract][Full Text] [Related]
12. Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu,Zn superoxide dismutase.
Couillard-Després S; Meier J; Julien JP
Neurobiol Dis; 2000 Aug; 7(4):462-70. PubMed ID: 10964615
[TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase--applications and relevance to human diseases.
Noor R; Mittal S; Iqbal J
Med Sci Monit; 2002 Sep; 8(9):RA210-5. PubMed ID: 12218958
[TBL] [Abstract][Full Text] [Related]
14. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
Gomes C; Keller S; Altevogt P; Costa J
Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
16. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury.
Bayir H; Kagan VE; Clark RS; Janesko-Feldman K; Rafikov R; Huang Z; Zhang X; Vagni V; Billiar TR; Kochanek PM
J Neurochem; 2007 Apr; 101(1):168-81. PubMed ID: 17394464
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
Urushitani M; Ezzi SA; Julien JP
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
[TBL] [Abstract][Full Text] [Related]
18. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation.
Tan CF; Piao YS; Hayashi S; Obata H; Umeda Y; Sato M; Fukushima T; Nakano R; Tsuji S; Takahashi H
Acta Neuropathol; 2004 Oct; 108(4):332-6. PubMed ID: 15235802
[TBL] [Abstract][Full Text] [Related]
19. ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury.
Guo Z; Kindy MS; Kruman I; Mattson MP
J Cereb Blood Flow Metab; 2000 Mar; 20(3):463-8. PubMed ID: 10724110
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism of ALS and a possible gene therapy].
Abe K; Warita H
Rinsho Shinkeigaku; 1999 Jan; 39(1):68-9. PubMed ID: 10377808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
